Navigation Links
Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
Date:3/21/2013

cated to the clinical development of new drugs for underserved therapeutic needs in large and growing markets. The company is focused on two lead phase II clinical compounds: Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration, and OHR/AVR118 for the treatment of cancer cachexia. Additional information on the company can be found at www.ohrpharmaceutical.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: 
This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made only as the date thereof, and Ohr Pharmaceutical undertakes no obligation to update or revise the forward-looking statement whether as a result of new information, future events or otherwise. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments, the financial resources available to us, and general economic conditions. For example, there can be no assurance that Ohr will be able to sustain operations for expected periods. Shareholders and prospective investors are cautioned that no assurance of the efficacy of pharmaceutical products can be claimed or assured until final testing; and no assurance or warranty can be made that the FDA or Health Canada will approve final testing or marketing of any pharmaceutical product. Ohr's most recent Annual Report and subsequent Quarterly Reports discuss some of the important risk factors that may affect our business, results of operations and financia
'/>"/>

SOURCE Ohr Pharmaceutical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Galderma, One of the Leading Pharmaceutical Companies, Relies on Verizon Enterprise Solutions to Provide Expanded, Secure Global Communications Platform
2. ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year
3. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
4. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
5. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
6. Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
7. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
8. National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
9. Pharmaceutical Distribution Agreement Between Cardinal Health And Walgreens To End August 2013
10. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
11. Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014  ePharmaSolutions, the leading ... as the Disruptive Innovator of the Year ... eClinical platform. This solution includes an integrated ... file (eTMF), a remote monitoring application, eSource ... patient screening and matching technology. ...
(Date:9/18/2014)... ARBOR, Mich. , Sept. 18, 2014  A ... Research will allow the University of Michigan to establish ... The Glenn Center for Aging Research at ... evidence that drugs can slow the effects of aging ... unlock mechanisms of aging that can help develop medications ...
(Date:9/18/2014)... , Sept. 18, 2014   3D Systems   (NYSE: ... Simbionix RobotiX Mentor™ , a new robotic surgery skills ... first time at the ERUS exhibition in Amsterdam, ... #7). Robotic-assisted minimally invasive surgery represents a growing ... the needs for training for robotic surgery has increased, and ...
Breaking Medicine Technology:ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 33D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3
(Date:9/18/2014)... TayganPoint Consulting Group, a leading ... and co-founder John Cassimatis was named as one ... 2014, recognizing the region’s top healthcare and life ... of the year. , The Innovation Awards celebrate ... continue to shape the medical industry in Greater ...
(Date:9/18/2014)... Ben Quirk, CEO of Quirk Healthcare Solutions, was ... the Savannah Science Seminar in recognition for the firm’s ... and especially in Savannah. , “I am humbled and ... Science Seminar is an amazing program that has been ... through the program,” he added. Eleventh graders from private ...
(Date:9/18/2014)... of international scientists have developed a new method to ... . , The Wildlife Conservation Society (WCS)-led research, published ... , describes the use of fecal samples from wild ... exposed to the virus. This represents a new tool ... change the way Ebola virus is studied and improve ...
(Date:9/18/2014)... The National Institutes of Health (NIH) recently awarded the ... grant to the Los Angeles Biomedical Research Institute (LA ... a vaccine to protect patients from the healthcare-related infections, ... (MRSA). , The National Institute of Allergy and ... to LA BioMed infectious disease specialists John E. Edwards, ...
(Date:9/18/2014)... been trying to develop tools that would allow them ... first moment a neuron fires to the resulting behavior ... neuroscientists are working to develop a range of new ... developed one such tool that provides a new way ... The worka collaboration between Viviana Gradinaru (BS ,05), assistant ...
Breaking Medicine News(10 mins):Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:Sensing neuronal activity with light 2Health News:Sensing neuronal activity with light 3Health News:Sensing neuronal activity with light 4Health News:Sensing neuronal activity with light 5
... SHENZHEN, CHINA , March 15 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/ ) is pleased to announce that the Chilean government approved two of the company,s ... ... ... ...
... by dying cancer patients to the emergency department can be ... Canadian Medical Association Journal ( CMAJ ) (pre-embargo ... patients visit the emergency department in the last 2 weeks ... often and why people dying of cancer visit the emergency ...
... locating and avoiding nerves during spinal procedures, suggests a ... issue becomes important for patients as the demand for ... the need for effective methods for monitoring the location ... Mechanomyography (MMG) systems function by measuring the mechanical ...
... boost outcomes after 12 months, new study finds , MONDAY, ... alone to patients who have had stents implanted seems just ... Plavix, a new study finds. , Researchers discovered that, after ... went off Plavix and just took aspirin had the same ...
... Each year, nearly three million youths run away from home, ... mental illness.  In honor of National Safe Place Week, National Safe Place ... to raise awareness of the risks associated with teen homelessness and the ... youth in crisis.   , ...
... Open defecation – the riskiest sanitation practice – is on the decline worldwide , ... , , ... ... GENEVA and NEW YORK , March ...
Cached Medicine News:Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 2Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 3Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 4Health News:Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile 5Health News:Dying cancer patient visits to emergency departments can be avoided 2Health News:Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery 2Health News:Aspirin Alone Works Best to Prevent Clots a Year After Stenting 2Health News:Aspirin Alone Works Best to Prevent Clots a Year After Stenting 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 2Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 4Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 5Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 6Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 7Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 8Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 2Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 3Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 4Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 5Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 6Health News:Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts 7
2 mm wide tip with 1 mm by 4 mm eye. Curved shaft and ring handle with polished finish....
Coaptation forceps. Insulated....
Titanium bayonet forceps. Insulated....
Gerald bayonet forceps. Insulated....
Medicine Products: